These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31474633)

  • 1. [Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis].
    Nakamoto K; Tokuyama S
    Yakugaku Zasshi; 2019; 139(9):1169-1175. PubMed ID: 31474633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHA supplementation prevent the progression of NASH via GPR120 signaling.
    Nakamoto K; Shimada K; Harada S; Morimoto Y; Hirasawa A; Tokuyama S
    Eur J Pharmacol; 2018 Feb; 820():31-38. PubMed ID: 29221950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway.
    Nakamoto K; Tokuyama S
    Pharmacology; 2022; 107(5-6):330-338. PubMed ID: 35189618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice.
    Kiepura A; Suski M; Stachyra K; Kuś K; Czepiel K; Wiśniewska A; Ulatowska-Białas M; Olszanecki R
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):667-678. PubMed ID: 36705799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatically-epoxidized docosahexaenoic acid, 19,20-EpDPE, suppresses hepatic crown-like structure formation and nonalcoholic steatohepatitis fibrosis through GPR120.
    Aoki H; Isobe Y; Yoshida M; Kang JX; Maekawa M; Arita M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Mar; 1868(3):159275. PubMed ID: 36566874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-Protein-Coupled Receptors 120 Agonist III Improves Hepatic Inflammation and ER Stress in Steatohepatitis.
    Chen X; Liu C; Ruan L
    Dig Dis Sci; 2021 Apr; 66(4):1090-1096. PubMed ID: 32372191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
    Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
    Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RLA8-A New and Highly Effective Quadruple PPAR-
    Li MH; Chen W; Wang LL; Sun JL; Zhou L; Shi YC; Wang CH; Zhong BH; Shi WG; Guo ZW
    J Pharmacol Exp Ther; 2019 Apr; 369(1):67-77. PubMed ID: 30745416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Adv Nutr; 2015 Nov; 6(6):694-702. PubMed ID: 26567194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.
    Nobili V; Carpino G; Alisi A; De Vito R; Franchitto A; Alpini G; Onori P; Gaudio E
    PLoS One; 2014; 9(2):e88005. PubMed ID: 24505350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR120 protects lipotoxicity-induced pancreatic β-cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation.
    Wang Y; Xie T; Zhang D; Leung PS
    Clin Sci (Lond); 2019 Jan; 133(1):101-116. PubMed ID: 30523046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
    Cheng Y; Chen T; Ping J; Chen J
    Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.
    Shewale SV; Brown AL; Bi X; Boudyguina E; Sawyer JK; Alexander-Miller MA; Parks JS
    J Lipid Res; 2017 Jan; 58(1):236-246. PubMed ID: 27811230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
    Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
    Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
    Luo F; Ishigami M; Achiwa K; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Katano Y; Goto H
    Dig Dis Sci; 2015 Sep; 60(9):2730-9. PubMed ID: 25868633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.